A randomized phase II study of nivolumab or nivolumab combined with ipilimumab in patients (pts) with melanoma brain metastases (mets): The Anti-PD1 Brain Collaboration (ABC)

Georgina V. Long, Victoria Atkinson, Alexander M. Menzies, Serigne Lo, Alexander David Guminski, Michael Paul Brown, Maria Magdalena Gonzalez, Katrina Diamante, Shahneen Kaur Sandhu, Richard A. Scolyer, Louise Emmett, Grant A. McArthur

University of Sydney, Sydney, Australia
University of Queensland, Brisbane, Australia
Melanoma Institute Australia, Royal North Shore Hospital, The University of Sydney, Sydney, Australia
Melanoma Institute Australia, Sydney, Australia
Medical Oncology Department, Royal North Shore Hospital, St. Leonards, Australia
Royal Adelaide Hospital, Adelaide, Australia
Providence St Joseph Medical Center, Newport Beach, CA
ANZMTG, Sydney, Australia
Peter MacCallum Cancer Centre, Melbourne, Australia
Royal Prince Alfred Hospital/Melanoma Institute Australia/University of Sydney, Sydney, Australia
St Vincent’s Clinic Medical Imaging and Nuclear Medicine, Darlinghurst, Australia
Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia